Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Hereditary paraganglioma syndrome has recently been shown to be caused by germline heterozygous mutations in three (SDHB, SDHC, and SDHD) of the four genes that encode mitochondrial succinate dehydrogenase. Extraparaganglial component neoplasias have never been previously documented. In a population-based registry of symptomatic presentations of phaeochromocytoma/paraganglioma comprising 352 registrants, among whom 16 unrelated registrants were SDHB mutation positive, one family with germline SDHB mutation c.847-50delTCTC had two members with renal cell carcinoma (RCC), of solid histology, at ages 24 and 26 years. Both also had paraganglioma. A registry of early-onset RCCs revealed a family comprising a son with clear-cell RCC and his mother with a cardiac tumor, both with the germline SDHB R27X mutation. The cardiac tumor proved to be a paraganglioma. All RCCs showed loss of the remaining wild-type allele. Our observations suggest that germline SDHB mutations can predispose to early-onset kidney cancers in addition to paragangliomas and carry implications for medical surveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, clinical similarities besides pheochromocytoma have been noted in families with germline mutations of VHL and SDHB [26].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [26]
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“00 cinate dehydrogenase (SDH), were described in families with head and neck PGLs (Baysal et al. 2000).”
BackgroundInfluentialThe Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · cited 6×
“It is interesting that germline FH mutations are associated with HLRCC (Tomlinson et al. 2002).”
BackgroundInfluentialOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationNickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940 · cited 2×
“Germline mutations in HRPT2 have been recently associated with hyperparathyroidism jaw tumor syndrome (MIM 145001), and germline mutations in BHD, encoding folliculin, have been associated with Birt-Hogg-Dubé syndrome (MIM 135150); both of these diseases have RCC as component tumors (Khoo et al. 2002; Nickerson et al.…”
BackgroundChen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442 · cited 4×
“Accumulation of reactive oxygen species could result from dysfunction in mitochondrial energy metabolism; results supporting this theory have been reported (Jeffers et al. 1997; Eng et al. 2003).”
BackgroundResultInfluentialA role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392 · cited 10×
“It is interesting that germline mutations in genes encoding two other subunits of SDH (mitochondrial complex II), SDHB (MIM 185470 and MIM 605373) and SDHC (MIM 602413), were found to be associated with heritable pheochromocytoma and/or PGL (Maher and Eng 2002; Eng et al. 2003).”
BackgroundResultInfluentialSelf-citation
Cited by
Items 101–200 of 387
Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery
Schimke, R. N., Collins, D. L., & Stolle, C. A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33384 · Cited by 84
“RCC, usually of the clear cell variety, is considered to be another associated tumor [Neumann et al., 2004; Vanharanta et al., 2004], and as noted in the present family.”
BackgroundSrirangalingam, U., Walker, L., Khoo, B. C. E., MacDonald, F., Gardner, D. S.-L., Wilkin, T. J., Skelly, R. H., George, E., Spooner, D. A., Monson, J. P., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03274.x · Cited by 93
Co-regulation of mitochondrial respiration by proline dehydrogenase/oxidase and succinate
Hancock, C. N., Liu, W., Alvord, W. G., & Phang, J. M. (2015) · Amino Acids · doi:10.1007/s00726-015-2134-7 · Cited by 92
Clinical implications of the oncometabolite succinate in SDHx ‐mutation carriers
Eijkelenkamp, K., Osinga, T. E., Links, T. P., & van der Horst‐Schrivers, A. N. A. (2019) · Clinical Genetics · doi:10.1111/cge.13553 · Cited by 103
“Eight RCC and multiple GISTs have been reported in SDHC carriers.(19,58,59) Two cases of pituitary adenoma have been described, although for LoH studies no tissue was available to prove pathogenicity.”
BackgroundGupta, S., Swanson, A. A., Chen, Y., Lopez, T., Milosevic, D., Kipp, B. R., Leibovich, B. C., Thompson, R. H., Herrera-Hernandez, L. P., Cheville, J. C., et al. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.07.004 · Cited by 80
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 87
Lee, J. P., Brauweiler, A., Rudolph, M., Hooper, J. E., Drabkin, H. A., & Gemmill, R. M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0491 · Cited by 76
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez‐Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 75
“Regarding other tumors related to SDH alterations, it has been described that germ-line SDHB mutations can predispose to early-onset kidney cancer in addition to paraganglioma (Vanharanta et al., 2004).”
BackgroundSuccinate Dehydrogenase-deficient Tumors: Diagnostic Advances and Clinical Implications
Barletta, J. A., & Hornick, J. L. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31825c6bc6 · Cited by 79
Renal cancer in von Hippel–Lindau disease and related syndromes
Bausch, B., Jilg, C. A., Gläsker, S., Vortmeyer, A. O., Lützen, N., Anton, A., Eng, C., & Neumann, H. P. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.144 · Cited by 79
Self-citationNeumann, H. P. H., Young, W. F., Krauß, T., Bayley, J., Schiavi, F., Opocher, G., Boedeker, C. C., Tirosh, A., Castinetti, F., Ruf, J., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0085 · Cited by 82
Self-citationThe Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 84
“In addition, SDHB was found mutated in renal carcinomas (92, 117), and mutations in several SDH genes have been associated with gastrointestinal stromal cancer, T cell leukemia, thyroid tumors, testicular seminoma, neuroblastomas, and pituitary tumors (9, 11).”
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 76
Clinical genomics of renal epithelial tumors
Hagenkord, J. M., Gatalica, Z., Jonasch, E. W., & Monzon, F. A. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.06.001 · Cited by 77
“There have been reports of chromophobe RCC in patients with germline mutations in SDHB (hereditary paraganglioma/pheochromocytoma) (7,57,59).”
BackgroundDistinct expression profile in fumarate-hydratase-deficient uterine fibroids
Vanharanta, S., Pollard, P. J., Lehtonen, H. J., Laiho, P., Sjöberg, J., Leminen, A., Aittomäki, K., Arola, J., Kruhoffer, M., Ørntoft, T. F., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi431 · Cited by 71
“Mutations in the SDH subunit genes SDHB, SDHC and SDHD, but not in SDHA, are associated with familial and sporadic pheochromocytoma and paraganglioma (2), and in the case of SDHB, also with renal cell carcinoma (3).”
BackgroundSelf-citationLussey‐Lepoutre, C., Bellucci, A., Morin, A., Buffet, A., Amar, L., Janin, M., Ottolenghi, C., Zinzindohoué, F., Autret, G., Burnichon, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1576 · Cited by 84
“3) or renal clear cell carcinomas (4).”
Evolving concepts in pheochromocytoma and paraganglioma
Dahia, P. L. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198017.45982.06 · Cited by 69
HIF and fumarate hydratase in renal cancer
Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 71
“However, there is one report of early onset RCC in three patients with germline SDHB mutations (Vanharanta et al, 2004).”
BackgroundA Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling
Yakirevich, E., Ali, S. M., Mega, A. E., McMahon, C., Brodsky, A. S., Ross, J. S., Allen, J. M., Elvin, J. A., Safran, H. P., & Resnick, M. B. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000403 · Cited by 71
Nephron-sparing surgery for multifocal and hereditary renal tumors
Metwalli, A. R., & Linehan, W. M. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000094 · Cited by 69
“Careful clinical decision-making and surgical techniques are required to manage HLRCC and SDH-related tumors.”
BackgroundInfluentialCellular oxygen sensing in health and disease
Mole, D. R., & Ratcliffe, P. J. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0632-x · Cited by 79
Housley, S. L., Lindsay, R. S., Young, B., McConachie, M., Mechan, D., Baty, D. U., Christie, L., Rahilly, M., Qureshi, K. N., & Fleming, S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03482.x · Cited by 70
“Ionescu et al.4 proposed a practical scheme including the main differential diagnoses when dealing with a pulmonary nodular histiocytic proliferation.”
BackgroundInfluentialThe role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 76
Qin, Y., Deng, Y., Ricketts, C. J., Srikantan, S., Wang, E., Maher, E. R., & Dahia, P. L. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt638 · Cited by 70
“In familial paraganglioma type (PGL4), caused by germline mutations in SDHB, patients can develop paraganglial tumors, some presenting with concurrent RCC (7), and, more recently SDHB mutations have also been reported in patients presenting with RCC alone (4,6).”
BackgroundMetabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 66
Sudarshan, S., Pinto, P. A., Neckers, L., & Linehan, W. M. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0711 · Cited by 65
“In all three cases (two of the three patients were members of the same family), RCC was diagnosed when these individuals were in their 20s”
BackgroundTumours of familial origin in the head and neck
Suarez, C. M., Rodrigo, J. P., Ferlito, A., Cabanillas, R., Shaha, A. R., & Rinaldo, A. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.03.002 · Cited by 80
MANAGEMENT OF ENDOCRINE DISEASE: Clinical management of paragangliomas
Corssmit, E. P. M., & Romijn, J. A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0396 · Cited by 67
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
“In particular, family history of HNPGL/PPGL, multiple tumors, extra-adrenal location, or early age at diagnosis (mean age at diagnosis in SDHB/SDHD-related tumors is w10 years earlier than in sporadic cases) can be used to stratify the likelihood of a germline mutation being detected and so increase cost-effectiveness…”
BackgroundInfluentialCholesterol and the development of clear-cell renal carcinoma
Drabkin, H. A., & Gemmill, R. M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.08.002 · Cited by 70
Jha, A., de Luna, K. S., Balili, C. A., Millo, C., Paraiso, C. A., Ling, A. L., Gonzales, M. K., Viana, B., Alrezk, R., Adams, K. T., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00053 · Cited by 64
MacFarlane, J., Seong, K. C., Bisambar, C., Madhu, B., Allinson, K. S. J., Marker, A. J., Warren, A. Y., Park, S., Giger, O., Challis, B., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14289 · Cited by 70
“Currently the accepted spectrum of hereditary tumours associated with germline SDHx mutations include; phaeochromocytoma (PC) and paraganglioma (PGL) (4) , gastrointestinal stromal tumours (GIST) (5), renal cell carcinoma (RCC) (6) and pituitary adenomas (7).”
BackgroundHenderson, A., Douglas, F., Perros, P., Morgan, C., & Maher, E. R. (2009) · Familial Cancer · doi:10.1007/s10689-009-9234-z · Cited by 60
“However, despite the similarities in mechanisms of tumourigenesis between VHL, FH and SDHB associated tumours, RCC has rarely been reported in association with SDHB mutations [6, 7 ]. Instead, SDHB mutations are recognised as one of the causes of hereditary paraganglioma syndrome [8].”
BackgroundMalinoc, A., Sullivan, M., Wiech, T., Schmid, K. W., Jilg, C. A., Straeter, J., Değer, S., Hoffmann, M. M., Bosse, A., Rasp, G., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0324 · Cited by 62
“Recently, heritable ccRCC associated with pheochromocytoma and paraganglioma has been described as a consequence of germline heterozygous mutations of the gene-encoding subunit B of the enzyme SDHB by at least two independent groups (Vanharanta et al. 2004, Ricketts et al. 2008).”
BackgroundInfluentialSelf-citationGenetic basis of phaeochromocytoma and paraganglioma
Benn, D. E., & Robinson, B. G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.005 · Cited by 58
Guo, Y., Cai, Q., Samuels, D. C., Ye, F., Long, J., Li, C.-I., Winther, J. F., Tawn, E. J., Stovall, M., Lähteenmäki, P., et al. (2012) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2012.02.006 · Cited by 57
Penetrance and clinical consequences of a gross SDHB deletion in a large family
Solis, D. C., Burnichon, N., Timmers, H., Raygada, M. J., Kozupa, A., Merino, M. J., Makey, D., Adams, K. T., Vénisse, A., Gimenez‐Roqueplo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01157.x · Cited by 57
Astuti, D., Ricketts, C. J., Chowdhury, R., McDonough, M. A., Gentle, D., Kirby, G., Schlisio, S., Kenchappa, R. S., Carter, B. D., Kaelin, W. G., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0113 · Cited by 55
“In addition, germline mutations in VHL, SDHB and SDHD are associated with susceptibility to renal cell carcinoma (RCC), though the risk of RCC is about five times higher in VHL disease (Maher et al. 1990, Latif et al. 1993, Vanharanta et al. 2004, Ong et al. 2007, Ricketts et al. 2008, 2010).”
BackgroundCarney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency
Pitsava, G., Settas, N., Faucz, F. R., & Stratakis, C. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.680609 · Cited by 61
“SDH-deficient renal carcinoma was first recognized in 2004 (22) and later was accepted as a distinct type of renal cell carcinoma (RCC) (4, 105).”
BackgroundLima, J., Feijão, T., Ferreira da Silva, A., Pereira-Castro, I., Fernandez-Ballester, G., Máximo, V., Herrero, A., Serrano, L., Sobrinho-Simões, M., & Garcia-Rostan, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0640 · Cited by 54
Metabolic alterations in hereditary and sporadic renal cell carcinoma
Coffey, N. J., & Simon, M. C. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00800-2 · Cited by 56
“SDH-deficient RCC develops from the germline or sporadic loss of the succinate dehydrogenase (SDH) complex, which is also associated with the presence of paragangliomas, pheochromocytomas and GI stromal tumours 75 (Fig.”
Pithukpakorn, M., Wei, M.-H., Toure, O., Steinbach, P. J., Glenn, G. M., Zbar, B., Linehan, W. M., & Toro, J. R. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041087 · Cited by 56
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 58
“Some patients with SDHBmutations have also been reported to develop renal cell carcinoma [79].”
BackgroundMitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential
Wagner, A., Kosnacova, H., Chovanec, M., & Jurkovičová, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147897 · Cited by 57
Özlük, Y., Taheri, D., Matoso, A., Şanlı, Ö., Berker, N. K., Yakirevich, E., Balasubramanian, S., Ross, J. S., Ali, S. M., & Netto, G. J. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.027 · Cited by 51
Genetic Basis of Cancer of the Kidney
Sudarshan, S., & Linehan, W. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.008 · Cited by 56
Aldera, A. P., & Govender, D. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204677 · Cited by 54
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 50
“In addition, renal cell carcinoma and T-cell acute leukemia are also associated with SDHB mutations [67,68].”
BackgroundErlic, Z., & Neumann, H. P. H. (2009) · HORMONES · doi:10.14310/horm.2002.1219 · Cited by 50
“Whilst RCC is associated with mutations in the SDHB gene, mutation in all three genes have been identified in patients with the Carney-Stratakis dyad of paraganglioma and gastric stromal tumour.(42,43)”
BackgroundSelf-citationThe Genetic Basis of Pheochromocytoma and Paraganglioma: Implications for Management
Shuch, B. M., Ricketts, C. J., Metwalli, A. R., Pacák, K., & Linehan, W. M. (2014) · Urology · doi:10.1016/j.urology.2014.01.007 · Cited by 47
Anticancer effects of metformin on neuroendocrine tumor cells in vitro
Vlotides, G., Tanyeri, A., Spampatti, M. P., Zitzmann, K., Chourdakis, M., Spöttl, G., Maurer, J., Nölting, S., Göke, B., & Auernhammer, C. J. (2014) · HORMONES · doi:10.14310/horm.2002.1517 · Cited by 50
MacLennan, G. T., & Liang Cheng, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-23380-2_35 · Cited by 44
The power of yeast to model diseases of the powerhouse of the cell
Claypool, S. M. (2012) · Frontiers in bioscience · doi:10.2741/4098 · Cited by 50
“Mutations in SDH also cause autosomal dominant inheritable forms of cancer, such as head and neck paragangliomas, pheochromocytomas (217), and renal cell cancer (223).”
BackgroundRenal Cell Carcinoma in Young Patients: a Review of Recent Literature
Daugherty, M. R., & Bratslavsky, G. (2015) · Current Urology Reports · doi:10.1007/s11934-014-0473-7 · Cited by 43
Casey, R. T., Warren, A. Y., Martín, J., Challis, B., Rattenberry, E., Whitworth, J., Andrews, K. A., Roberts, T., Clark, G. R., West, H. D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00562 · Cited by 43
“This finding expands the phenotype associated withMAXmutations and raises the intriguing possibility that MAX may be a candidate gene for inherited RCC [SDHB mutations were originally described in association with PC/PGL/HNPGL (26), then with RAPTAS (20), and then familial RCC-only (16) phenotypes].”
The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors
Xekouki, P., Brennand, A., Whitelaw, B., Pacák, K., & Stratakis, C. A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0661-0341 · Cited by 50
Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas
Martucci, V. L., Emaminia, A., Rivero, J. D., Lechan, R. M., Magoon, B. T., Galia, A., Fojo, T., Leung, S., Lorusso, R., Jiménez, C., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.020 · Cited by 41
Linehan, W. M., Srinivasan, R., & Garcia, J. A. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.05.009 · Cited by 42
Kuroda, N., Yorita, K., Nagasaki, M., Harada, Y., Ohe, C., Jeruc, J., Raspollini, M. R., Michal, M., Hes, O., & Amin, M. B. (2016) · Polish Journal of Pathology · doi:10.5114/pjp.2016.59227 · Cited by 41
Aghamir, S. M. K., Heshmat, R., Ebrahimi, M., Ketabchi, S. E., Parichehreh-Dizaji, S., & Khatami, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207460 · Cited by 41
“, solid) must be observed to take an extended family history and SDHB mutant-related RCC in the way of better diagnosis and prognosis.(35,36) In fact the weak staining, particularly in clear neoplasms, usually can be interpreted as negative by mistake.”
BackgroundGenetics of pheochromocytoma and paraganglioma
Wachtel, H., & Fishbein, L. M. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000634 · Cited by 45
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer
Ni, Y., Seballos, S. S., Ganapathi, S. S., Gurin, D., Fletcher, B., Ngeow, J. Y. Y., Nagy, R. S., Kloos, R. T., Ringel, M. D., LaFramboise, T., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0537 · Cited by 43
“It was noticed that a rare subset of individuals with germline SDHB or SDHD mutations in the European–American pheochromocytoma registry had renal cancers and papillary thyroid cancer (PTC) (Neumann et al. 2004, Vanharanta et al. 2004).”
Self-citationSuccinate Dehydrogenase–Deficient Renal Cell Carcinoma
Tsai, T.-H., & Lee, W. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0024-rs · Cited by 39
Mapping of Succinate Dehydrogenase Losses in 2258 Epithelial Neoplasms
Miettinen, M., Sarlomo‐Rikala, M., McCue, P. A., Czapiewski, P., Langfort, R., Waloszczyk, P., Ważny, K., Biernat, W., Lasota, J. P., & Wang, Z. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31828bfdd3 · Cited by 41
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours
Srirangalingam, U., Khoo, B. C. E., Walker, L., MacDonald, F., Skelly, R. H., George, E., Spooner, D. A., Johnston, L., Monson, J. P., Grossman, A. B., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0239 · Cited by 41
“SDHB gene mutations have already been associated with extra-adrenal disease, a high risk of malignancy and renal cell carcinoma (Neumann et al. 2004, Vanharanta et al. 2004, Benn et al. 2006, Timmers et al. 2007, Ricketts et al. 2008, Srirangalingam et al. 2008).”
BackgroundSuccinate Dehydrogenase–Deficient Renal Cell Carcinoma: A Short Review
Wang, G., & Rao, P. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0199-rs · Cited by 39
Tufton, N., Shapiro, L., Srirangalingam, U., Richards, P. S., Sahdev, A., Kumar, A., McAndrew, L., Martin, L., Berney, D. M., Monson, J. P., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13246 · Cited by 39
Casey, R. T., McLean, M. A., Madhu, B., Challis, B., ten Hoopen, R., Roberts, T. A., Clark, G. R., Pitfield, D., Simpson, H., Bulusu, V. R., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00191 · Cited by 40
Oudijk, L., Gaal, J., & de Krijger, R. R. (2018) · Endocrine Pathology · doi:10.1007/s12022-018-9555-2 · Cited by 38
Metabolic Drivers in Hereditary Cancer Syndromes
Sciacovelli, M., Schmidt, C., Maher, E. R., & Frezza, C. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033612 · Cited by 48
Screening for familial paragangliomas
Myssiorek, D. J., Ferlito, A., Silver, C. E., Rodrigo, J. P., Baysal, B. E., Fagan, J. J., Suarez, C. M., & Rinaldo, A. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.010 · Cited by 41
Mendelian genetics of rare—and not so rare—cancers
Eng, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05789.x · Cited by 36
Self-citationGrowth Rate of Paragangliomas Related to Germline Mutations of the SDHx Genes
Michałowska, I. M., Ćwikła, J. B., Michalski, W., Wyrwicz, L. S., Prejbisz, A., Szperl, M., Nieć, D., Neumann, H. P. H., Januszewicz, A., & Pęczkowska, M. (2016) · Endocrine Practice · doi:10.4158/ep161377.or · Cited by 38
Self-citationZbar, B., Glenn, G. M., Merino, M. J., Middelton, L. A., Peterson, J. C., Toro, J. R., Coleman, J., Pinto, P. A., Schmidt, L. S., Choyke, P. L., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.09.037 · Cited by 35
Kitazawa, S., Ebara, S., Ando, A., Baba, Y., Satomi, Y., Soga, T., & Hara, T. (2017) · Oncotarget · doi:10.18632/oncotarget.15959 · Cited by 35
Pituitary carcinoma: Two case reports and review of literature
Xu, L., Khaddour, K., Chen, J., Rich, K. M., Perrin, R. J., & Campian, J. L. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i2.91 · Cited by 38
Hamza, A., Sirohi, D., Smith, S. C., & Amin, M. B. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000321 · Cited by 37
Zhang, D., Wang, W., Xiang, B., Li, N., Huang, S., Zhou, W., Sun, Y., Wang, X., Ma, J., Li, G., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-0781-4 · Cited by 36
“A series of studies indicated that the mutations in SDH were associated with tumor formation including PGLs [11, 12, 22], GIST [10, 23], thyroid cancer [24], renal tumors, and neuroblastoma [14, 25, 26].”
BackgroundBatova, A., Altomare, D., Creek, K. E., Naviaux, R. K., Wang, L., Li, K., Green, E., Williams, R. T., Naviaux, J. C., Diccianni, M. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172632 · Cited by 34
Tufton, N., Sahdev, A., Drake, W. M., & Akker, S. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13877 · Cited by 35
Ricci, L., Stanley, F. U., Eberhart, T., Mainini, F., Sumpton, D. P., & Cardaci, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05927-5 · Cited by 40
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 35
“Additional solid tumors such as gastrointestinal stromal tumors (GISTs) [7], clear cell renal cell carcinomas (ccRCCs) [8] and pituitary adenomas (PAs) [9] have been associated, albeit rarely, with these familial PGL syndromes [10].”
BackgroundBayley, J., Bausch, B., Rijken, J. A., van Hulsteijn, L. T., Jansen, J. C., Ascher, D. B., Pires, D. E. V., Hes, F. J., Hensen, E. F., Corssmit, E. P. M., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106214 · Cited by 33
Self-citationRole of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Zhao, Y., Feng, F., Guo, Q., Wang, Y., & Zhao, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5074 · Cited by 52
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 38
“More recently, mutations in succinate dehydrogenase genes (SDHB, SDHC and SDHD), which predispose to familial paraganglioma and pheochromocytomas, have also been detected in RCC [6, 7].”
BackgroundKuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 33
10 rare tumors that warrant a genetics referral
Banks, K. C., Moline, J., Marvin, M. L., Newlin, A. C., & Vogel, K. J. (2012) · Familial Cancer · doi:10.1007/s10689-012-9584-9 · Cited by 33
Hereditary causes of kidney tumours
Axwijk, P., Kluijt, I., de Jong, D., Gille, H., Teertstra, J., & Horenblas, S. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02270.x · Cited by 30
Elliott, R. L., & Head, J. F. (2012) · Journal of Cancer Therapy · doi:10.4236/jct.2012.34039 · Cited by 33
“However, it is important to note that germline mutations in these genes can lead to development of clear cell renal cell carcinoma and pheochromoctyoma [73,74].”
BackgroundMaternal Transmission of Symptomatic Disease withSDHDMutation: Fact or Fiction?
Neumann, H. P. H., & Erlic, Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0569 · Cited by 31
Self-citationPrecision Surgery and Kidney Cancer: Knowledge of Genetic Alterations Influences Surgical Management
Gomella, P. T., Linehan, W. M., & Ball, M. W. (2021) · Genes · doi:10.3390/genes12020261 · Cited by 32
“Originally described in 2004, mutations in the SDHB subunit are the most frequently seen in SDH‐deficient RCC [38].”
BackgroundNo evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome
Vahteristo, P., Koski, T. A., Näätsaari, L., Kiuru, M. H., Karhu, A., Herva, R., Sallinen, S., Kuismin, O., Björck, E., Richard, S., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9312-2 · Cited by 34
Self-citationDIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas
Mannelli, M., Canu, L., Ercolino, T., Rapizzi, E., Martinelli, S., Parenti, G., Filpo, G. D., & Nesi, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0523 · Cited by 30
Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review
Webster, B. R., Gopal, N., & Ball, M. W. (2022) · Genes · doi:10.3390/genes13112122 · Cited by 30
“Like other forms of hereditary RCC, SDH-RCC is inherited in an autosomal dominant fashion as a germline mutation to the succinate dehydrogenase complex, as initially described in 2004 before beingg officially recognized as a distinct form of RCC by the WHO’s RCC classification in 2016 [99,100].”
BackgroundMitochondrial Deficiencies in the Predisposition to Paraganglioma
Lussey‐Lepoutre, C., Buffet, A., Gimenez‐Roqueplo, A., & Favier, J. (2017) · Metabolites · doi:10.3390/metabo7020017 · Cited by 31
“described the first cases of RCC secondary to an SDHB germline mutation, which co-segregated with PPGL in a family [32].”
BackgroundThe Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
Nazar, E., Khatami, F., Saffar, H., & Tavangar, S. M. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i2.692 · Cited by 37
Cancer and the Kidney: The Growth of Onco-nephrology
Perazella, M. A., Berns, J. S., & Rosner, M. H. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.09.002 · Cited by 28
Increased HIF1α in SDH and FH deficient tumors does not cause microsatellite instability
Lehtonen, H. J., Mäkinen, M. J., Kiuru, M. H., Laiho, P., Herva, R., van Minderhout, I. J. H. M., Hogendoorn, P. C. W., Cornelisse, C. J., Devilee, P., Launonen, V., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22819 · Cited by 30
Self-citationCurrent Understanding of Mitochondrial DNA in Breast Cancer
Radpour, R., Fan, A. X., Kohler, C., Holzgreve, W., & Zhong, X. Y. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00767.x · Cited by 25
Lee, C., Gundem, G., Lee, W., Chen, Y., Cross, J. R., Dong, Y., Redzematovic, A., Mano, R., Wei, E. Y., Cheng, E. H. Y., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00007 · Cited by 27
“2%).(16,17) The most commonly Chung-Han Lee”
Metadata
- Authors
- Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., Mecklin, J.-P., Pukkala, E., Herva, R., Kiuru, M., Nupponen, N. N., Aaltonen, L. A., Neumann, H. P. H., & Eng, C.
- Affiliations
- University of Helsinki (FI)
- University of Freiburg (DE)
- The Ohio State University (US)
- Institute of Cardiology (PL)
- Helsinki University Hospital (FI)
- Central Finland Health Care District (FI)
- Finnish Cancer Registry (FI)
- Oulu University Hospital (FI)
- University of Cambridge (GB)
- Corresponding author
- Eng, Charis
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 74
- Issue
- 1
- Pages
- 153-159
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1181902
- OpenAlex
- W1977015709
- Cited by
- 389
- References
- 24
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 11 · 2022: 14 · 2021: 20 · 2020: 12 · 2019: 22 · 2018: 16 · 2017: 20 · 2016: 20 · 2015: 21 · 2014: 32 · 2013: 26 · 2012: 29
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3487 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (NE571/4-1)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039058, R01 HD39058, R01HD39058-02S1)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHB mutation, hereditary paraganglioma, succinate dehydrogenase, clear cell renal cell carcinoma, cardiac paraganglioma, germline mutations, loss of heterozygosity, cancer susceptibility, medical surveillance
- MeSH terms
- Adolescent, Adult, Base Sequence, Carcinoma, Renal Cell, Female, Humans, Iron-Sulfur Proteins, Kidney Neoplasms, Male, Paraganglioma, Pedigree, Succinate Dehydrogenase, Sequence Deletion, Age of Onset, Germ-Line Mutation, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits, Siblings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.